Document is current
Any future updates will be listed below
-
Authors
Safavi, Amir H.
Bryson, Emily
Delibasic, Victoria
Tjong, Michael C.
Hallet, Julie
Mahar, Alyson
Davis, Laura E.
Wright, Frances C.
Parmar, Ambica
Coburn, Natalie G.
Louie, Alexander V.
-
Funding
Funding for this research was provided by:
Ontario Institute for Cancer Research
- License Information
-
More Information
Article History
Accepted: 22 October 2023
First Online: 14 November 2023
Declarations
:
: Ethics approval was obtained from the Sunnybrook Research Ethics Board (#210607).
: Written informed consent was obtained from participants prior to study participation.
: JH has received honoraria from Ipsen and Advanced Accelerator Applications. NGC is the Clinical Lead for Patient-Reported Outcomes and Symptom Management for Ontario Health-Cancer Care Ontario. AVL has received honoraria from AstraZeneca. The other authors declare no conflicts of interest.
